Spotlight: Julie Bastarache, MD & Brandon Baer, PhD

Dr. Bastarache is a physician-scientist with a mechanistic and translational research program in acute and chronic lung diseases including acute respiratory distress syndrome (ARDS) and bronchiectasis. She also has an interest in non-pulmonary organ dysfunction during sepsis and studies delirium and acute kidney injury in experimental models. Her diverse research approach uses a combination of cell, mouse and human models of lung injury and repair to define the fundamental cellular and molecular mechanisms that regulate organ injury including ARDS, delirium and acute kidney injury as well large clinical and genetic datasets to generate insights into individual variability in risk and outcomes from ARDS. She also has an interest in leveraging the EMR and novel phenotyping methods to identify and study subjects with underlying genetic causes of chronic lung diseases such as bronchiectasis with the goal of developing tools to help clinicians achieve a timely and accurate diagnosis. Brandon Baer, PhD, is Postdoctoral Research Fellow in the Division of Allergy, Pulmonary and Critical Care Medicine at Vanderbilt University Medical Center. He is responsible for designing and executing research initiatives to assess novel therapeutics for respiratory disease. Over his career, he has initiated and led strategic approaches with both academic and biotech partners to enhance the efficacy as well as delivery of intrapulmonary therapeutics (mainly for the treatment of inflammation and infection). Passionate about improving the current treatment paradigms for respiratory disease, he thrives in collaborative environments that empower diverse teams of inter-disciplinary scientists to tackle scientific challenges.

Spotlight: Jennifer Shuman, PhD

Jennifer Shuman, PhD is a postdoctoral fellow in the Tim Cover lab in the department of Medicine and department of Pathology, Microbiology and Immunology. Jennifer received her BS in Genetics and in Microbiology from Clemson University in May 2018, where she worked with Dr. Ingram-Smith on Entamoeba histolytica metabolism. She graduated from the Interdisciplinary Graduate Program at Vanderbilt in the Spring of 2024 and is currently a postdoc in Dr. Tim Cover's lab. Her research interests include how Helicobacter pylori adapts to mixed infections and different environmental conditions. Outside of the lab, Jennifer likes to read, eat, and explore Nashville with her family.

Stephanie Rolsma, MD, PhD

Stephanie
Rolsma, MD, PhD
Assistant Professor
Pediatric Infectious Disease

Dr. Stephanie Rolsma is an assistant professor in the Division of Pediatric Infectious Diseases at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Dr. Rolsma has experience in microbiology, vaccine development, and clinical research and her current research focuses on therapeutics and interventions in critically ill patients and clinical trials. Her primary research focuses on evaluating the utility of therapeutic drug monitoring of beta-lactam antibiotics in pediatric and adult patients, including cystic fibrosis patients and patients receiving intensive critical care. She also serves as a co-investigator in studies conducted through the NIH-funded Vanderbilt Vaccine and Treatment Evaluation Unit (VTEU), including Moderna and Janssen Phase 3 SARS-CoV-2 vaccine trials in adults, a Moderna Phase 2/3 SARS-CoV-2 vaccine trial in children, a Moderna Phase 1 SARS-CoV-2 variant vaccine trial in adults, a study of infant immune responses to RSV, and an intranasal influenza vaccine in pediatric patients. As a co-investigator for the CDC-funded Clinical Immunization Safety Assessment Network she works to address safety issues and clinical adverse events following vaccinations.

Dr. Rolsma received her B.S. in Microbiology from Michigan State University. She was awarded a Ph.D. in Microbiology and Molecular Genetics and M.D. from the Medical College of Wisconsin, where she was a part of the Medical Scientist Training Program. She completed a residency in pediatrics and a fellowship in pediatric infectious diseases at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

stephanie.l.rolsma@vumc.org

vaccine, vaccine safety, antibiotic pharmacokinetics/pharmacodynamics, therapeutic drug monitoring